NN
Last reporting period 30 Jun, 2024
Updated —
Last price
—
Market cap $B
64.868
Exchange
XWBO - Wiener Boerse AG
39 %
Last period Average growth rate (2y)
41%
Average growth rate (2y) has increased in 5 years
What is Average growth rate (2y) ?
An indicator of the average growth rate of the company's profit relative to the same periods of previous years in the medium-term retrospective.
See also Novo Nordisk
Company Analysis
NNOR.VI valuation, rating, competitors, insights and company profile
Eyestock Rating
NNOR.VI financial analysis by Eyestock methodology
Valuation
NNOR.VI valuation using historical relative method
Statements
NNOR.VI Income Statements, Balance Sheet and Cash Flow Statements
Dividends
NNOR.VI dividend yield and annual dividend
An indicator of the average growth rate of the company's profit relative to the same periods of previous years in the medium-term retrospective.
Novo Nordisk`s Average growth rate (2y) for the period ended 2024-06-30 is 39 %
